CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (6,711,026)	$ (6,095,953)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	799,023	115,147
Amortization	162,415	33,358
Amortization of right-of-use assets	32,165
Interest expense - debt discount	1,491,065	3,051,148
Accretion of original issue discount on notes receivable - related party	(612,309)	(485,031)
Accretion of original issue discount on notes receivable	(49,505)
Stock-based compensation	621,288	1,438,214
Realized losses on sale of digital currencies	654
Realized losses on sale of marketable equity securities	13,344	41,784
Unrealized gains on marketable equity securities	(105,391)
Unrealized losses on equity securities - related party	139,184
Unrealized losses on equity securities	699
Changes in operating assets and liabilities:
Accounts receivable	(824,120)	344,137
Accounts receivable, related party	(27,421)	(1,792,892)
Accrued revenue	(182,293)
Digital currencies	(30,307)	(166,180)
Inventories	453,775	(215,786)
Prepaid expenses and other current assets	(102,479)	604,485
Other assets	(155,616)	(380,714)
Accounts payable and accrued expenses	3,180,861	527,189
Accounts payable, related parties	2,472	11,022
Other current liabilities	(358,717)	10,946
Net cash used in operating activities	(2,262,239)	(2,959,126)
Cash flows from investing activities:
Purchase of property and equipment	(9,606)	(7,478,335)
Purchase of intangible asset		(3,025)
Investments - related party	(740,948)	(146,780)
Investments in derivative instruments and common stock - related party	(302,214)	(1,555,461)
Investments in marketable equity securities		(657,273)
Sales of marketable equity securities	286,656	430,375
Proceeds from loans to related parties		16,088
Investments in debt and equity securities	(205,125)	(370,500)
Net cash used in investing activities	(971,237)	(9,764,911)
Cash flows from financing activities:
Gross proceeds from sales of common stock and warrants	4,397,535	6,243,355
Proceeds from issuance of Series A Convertible Preferred Stock	1,645
Financing cost in connection with sales of equity securities	(250,141)	(858,668)
Proceeds from stock option exercises		97,740
Proceeds from warrant exercises		867,166
Proceeds from convertible notes payable		1,000,000
Proceeds from notes payable	500,000	8,550,000
Proceeds from short-term advances - related party	54,200	50,000
Proceeds from short-term advances	47,000	762,000
Payments on short-term advances		(425,000)
Payments on notes payable	(228,749)	(5,246,875)
Payments on convertible notes payable	(809,253)
Proceeds from advances on future receipts	319,729	2,990,277
Payments on advances on future receipts	(313,221)	(1,916,523)
Payments of preferred dividends	(1,869)
Payments on revolving credit facilities, net	(7,375)	(220,815)
Net cash provided by financing activities	3,709,501	11,892,657
Effect of exchange rate changes on cash and cash equivalents	(94,747)	(16,753)
Net increase (decrease) in cash and cash equivalents	381,278	(848,133)
Cash and cash equivalents at beginning of period	902,329	1,478,147
Cash and cash equivalents at end of period	1,283,607	630,014
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	232,925	100,000
Non-cash investing and financing activities:
Cancellation of convertible note payable into shares of common stock	2,608,457	2,167,844
Payment of accounts payable with digital currency	26,963
Issuance of common stock for prepaid services		$ 1,924,339